The National Animal Poison Control Center received 28 calls of isoniaz
id (INH) exposures in dogs and cats between 1987 and 1993 The ingestio
n of a single 300 mg INH tablet was the most common complaint. Isoniaz
id has a low therapeutic margin and produces life threatening signs in
dogs ingesting single 300 mg human tablets. The LD(50) of INH in dogs
is estimated at 50 mg/kg bw, which is probably similar to that for hu
mans. However, rodents are among the species most resistant to INH and
thus are not good animal models for toxic dose extrapolation. The mor
e consistent clinical signs reported were recurrent clonic-tonic seizu
res followed by a stuporous state with poor response to stimulus. Idea
l treatment combines vitamin B-6 given as a single iv bolus at an equi
valent dose to the amount of INH ingested and anticonvulsants such as
1 mg diazepam/kg bw. This combination acts synergistically to improve
GABAergic transmission in the CNS and has proved effective in protecti
ng animals from further convulsions and death, even after several seiz
ure episodes, as often encountered in clinical situations.